Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TOCILIZUMAB”

419 trials

Showing 20 of 419 results

Testing effectiveness (Phase 2)Ended earlyNCT01727206
What this trial is testing

Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease

Who this might be right for
Erdheim-Chester Disease
Ospedale San Raffaele 3
Large-scale testing (Phase 3)UnknownNCT04693026
What this trial is testing

Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients

Who this might be right for
Covid19Covid-19 ARDS
M Abdur Rahim Medical College and Hospital 150
Not applicableStudy completedNCT01579006
What this trial is testing

Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 184
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999749
What this trial is testing

A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 71
Large-scale testing (Phase 3)Study completedNCT05489224
What this trial is testing

Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 471
Post-approval studies (Phase 4)Ended earlyNCT01661140
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 427
Large-scale testing (Phase 3)Study completedNCT01007435
What this trial is testing

Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,162
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Post-approval studies (Phase 4)Study completedNCT04157010
What this trial is testing

Tocilizumab REMission in Early RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 20
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Testing effectiveness (Phase 2)Study completedNCT01468077
What this trial is testing

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 47
Testing effectiveness (Phase 2)UnknownNCT04688021
What this trial is testing

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Who this might be right for
LeukemiaGraft-versus-host-disease
Yi Luo 46
Not applicableStudy completedNCT05394909
What this trial is testing

Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients

Who this might be right for
GCATOCILIZUMABGlucocorticoids+1 more
Azienda USL Reggio Emilia - IRCCS 20
Early research (Phase 1)Study completedNCT03522012
What this trial is testing

Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers

Who this might be right for
Pharmacokinetics
Mycenax Biotech Inc. 190
Post-approval studies (Phase 4)UnknownNCT01752335
What this trial is testing

Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hospital Universitario de Canarias 28
Not applicableUnknownNCT05017441
What this trial is testing

TOcilizumab and Covid-19 : Risk of Severe INfection

Who this might be right for
Covid19
Fondation Hôpital Saint-Joseph 1,200
Testing effectiveness (Phase 2)WithdrawnNCT06087731
What this trial is testing

Efficacy and Safety of Tocilizumab for TAO

Who this might be right for
TocilizumabThyroid Associated Ophthalmopathy
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT02929251
What this trial is testing

Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis

Who this might be right for
UveitisBiotherapy
Assistance Publique - Hôpitaux de Paris 112
Large-scale testing (Phase 3)Study completedNCT01668966
What this trial is testing

A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 23
Not applicableStudy completedNCT01669902
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation